Andrew P Dervan

5PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMedical mycologyCancer cell biologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 29, 2021
Genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma.

Matthew A Wall, Serdar Turkarslan, Wei-Ju Wu

|Nov 04, 2020
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.

Samuel A Danziger, Mark McConnell, Jake Gockley

|Feb 16, 2020
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease.

Mike J Mason, Carolina Schinke, Christine L P Eng

|Feb 07, 2020
Integrative network modeling reveals mechanisms underlying T cell exhaustion.

Hamid Bolouri, Mary Young, Joshua Beilke

|Sep 23, 2016
Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.

Andrew P Dervan, Patricia A Deverka, Julia R Trosman

Pageof 1

Frequent Collaborators

3 joint publications

Alexander V Ratushny

2 joint publications

Mary Young

2 joint publications

Samuel A Danziger

2 joint publications

Brian A Walker